ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Rifampicin Protects PC12 Cells from Rotenone-Induced Cytotoxicity by Activating GRP78 via PERK-eIF2 alpha-ATF4 Pathway

Jing Xiuna; Shi Qiaoyun; Bi Wei; Zeng Zhifen; Liang Yanran; Wu Xia; Xiao Songhua; Liu Jun; Yang Lianhong; Tao Enxiang*中山大学; 1
PLoS ONE2014-3-17DOI: 10.1371/journal.pone.0092110
3被引11阅读
引用收藏
分享

摘要

Rifampicin has been proposed as a therapeutic candidate for Parkinson's disease (PD). We previously showed that rifampicin was neuroprotective in PD models in vivo and in vitro. However, the molecular mechanisms underlying are not fully elucidated. In this study, using the comprehensive proteomic analysis, we identified that the 78 kDa glucose-regulated protein (GRP78), a hallmark of the unfolded protein response (UPR), was upregulated in rifampicin-treated PC12 cells. Western blot analysis confirmed GRP78 activation. GRP78 functions cytoprotectively in stressed cells, therefore, we hypothesized that GRP78 mediated rifampicin-induced neuroprotection. Using RNA interference, we found that GRP78 gene knockdown significantly attenuated the neuroprotective effects of rifampicin. Next, we examined three UPR transducers, namely, protein kinase RNA-like endoplasmic reticulum kinase (PERK), inositol requiring kinase alpha (IRE alpha) and activating transcription factor 6 (ATF 6), and how they regulated rifampicin-stimulated GRP78 expression. Our results showed that PERK, eukaryotic initiation factor 2 alpha (eIF2 alpha), and activating transcription factor 4 (ATF4) were activated in rifampicin-treated PC12 cells. Silencing the ATF4 gene using RNAi inhibited GRP78 stimulation. Interestingly, we did not detect significant IRE alpha activation, X-box binding protein 1 mRNA splicing, or ATF6 cleavage up to 24 h after rifampicin treatment. Taken together, our data suggested that rifampicin induced GRP78 via the PERK-eIF2 alpha-ATF4 pathway to protect neurons against rotenone-induced cell damage. Targeting molecules in this pathway could be a novel therapeutic approach for PD treatment.

相关
加载中…
  • Rifampicin and Parkinson's disease
    Bi Wei; Zhu Lihong; Jing Xiuna; Liang Yanran; Tao Enxiang*Neurological Sciences, 2013, 34(2): 137-141.被引 6
  • Cardinal role of eukaryotic initiation factor 2 (eIF2α) in progressive dopaminergic neuronal death & DNA fragmentation: Implication of PERK:IRE1α:ATF6 axis in Parkinson's pathology
    Sonam Gupta; Amit Mishra; Sarika SinghCellular Signalling, 2021, 109922.
  • Rifampicin Prevents SH-SY5Y Cells from Rotenone-Induced Apoptosis via the PI3K/Akt/GSK-3 beta/CREB Signaling Pathway
    Wu Xia; Liang Yanran; Jing Xiuna; Lin Danyu; Chen Ying; Zhou Tianen; Peng Sudan; Zheng Dezhi; Zeng Zhifen; Lei Ming; Huang Kaixun; Tao EnxiangNeurochemical Research, 2018, 43(4): 886-893.
查看全部 →

发表信息

论文状态
公开发表
期刊
PLoS ONE
发表日期
2014-03-17
卷期
第 9 卷, 第 3 期
页码
e92110
DOI
10.1371/journal.pone.0092110
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q1
成果收录
SCI
资助标注
National Natural Science Foundation of China (NSFC) [81371391]; Guangdong Provincial Department of Science and Technology [7001599, S2012010010731]; Ph.D. Programs Foundation of Ministry of Education of China [20070558257]

作者

  • J

    Jing Xiuna (第一作者)

    sun yat sen univ

  • S

    Shi Qiaoyun

查看全部 10 位作者收起作者
  • B

    Bi Wei

    1 · sun yat sen univ

  • Z

    Zeng Zhifen

    sun yat sen univ

  • L

    Liang Yanran

    sun yat sen univ

  • W

    Wu Xia

    sun yat sen univ

  • X

    Xiao Songhua

    sun yat sen univ

  • L

    Liu Jun

    sun yat sen univ

  • Y

    Yang Lianhong

    sun yat sen univ

  • T

    Tao Enxiang (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417